Inflammation is the body’s first line of defense against invading microbes, and it also plays an important role in eliminating diseased cells and damaged tissue in wounds and bruises. However, as we get older, inflammation turns against the body. Inflammation in cartilage is the proximate cause of arthritis, and in our arteries, inflammation creates the plaques which can lead to heart attacks and strokes. Inflammation damages DNA, and can turn healthy cells into cancers. SkQ1 demonstrated its potency in countering damaging aspects of the process of inflammation and treating several serious related disorders.

Within the framework of our project we conducted a set of animal studies proving efficacy of SkQ1 in fighting inflammation-related disorders such as

  • Non-infectious uveitis and
  • Rheumatoid arthritis.

More animal and human studies are underway in this important spectrum of therapeutic areas.